The importance of T-cell-mediated immunity to optimal vaccine responses is increasingly recognised, and T-cell correlates of vaccine efficacy [including type-1 cytokine production by peripheral T cells such as interferon-gamma (IFN-γ)] have been demonstrated in early-phase trials of leading COVID-19 vaccines [28, 29]. Here, IFNG is linked to COVID-19.